We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
-17.1%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.69B
AUM Growth
-$1.36B
(-19%)
Cap. Flow
-$72.7M
Cap. Flow
% of AUM
-1.28%
Top 10 Holdings %
Top 10 Hldgs %
17.58%
Holding
1,139
New
165
Increased
376
Reduced
380
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$58.3M |
| 2 |
CELG
Celgene Corp
CELG
|
+$27.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$23.3M |
| 4 |
TJX Companies
TJX
|
+$23.1M |
| 5 |
Synopsys
SNPS
|
+$19.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dell
DELL
|
+$45.2M |
| 2 |
Rockwell Automation
ROK
|
+$25.3M |
| 3 |
Accenture
ACN
|
+$24M |
| 4 |
Visteon
VC
|
+$23.4M |
| 5 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$22.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.85% |
| 2 | Financials | 17.71% |
| 3 | Consumer Discretionary | 12.6% |
| 4 | Healthcare | 11.49% |
| 5 | Industrials | 11.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HALL
801
DELISTED
Hallmark Financial Services, Inc.
HALL
| $325K | 0.01% |
3,043
-216
| -7% | -$23.6K |
|
802
QuinStreet
QNST
$870M
| $321K | 0.01% |
19,799
-5,755
| -23% | -$86.6K |
|
803
US Bancorp
USB
$99.6B
| $319K | 0.01% |
6,990
-1,110
| -14% | -$57.1K |
|
804
Upbound Group
UPBD
$1.19B
| $317K | 0.01% |
+19,580
| New | +$284K |
|
|
SCTL
805
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $317K | 0.01% |
49,800
+9,143
| +22% | +$57.2K |
|
|
ADVM
806
DELISTED
Adverum Biotechnologies
ADVM
| $313K | 0.01% |
9,933
+3,904
| +65% | +$159K |
|
|
WIRE
807
DELISTED
Encore Wire Corp
WIRE
| $311K | 0.01% |
6,200
| – | – |
|
|
ACC
808
DELISTED
American Campus Communities, Inc.
ACC
| $306K | 0.01% |
+7,400
| New | +$307K |
|
809
Adeia
ADEA
$2.86B
| $303K | 0.01% |
62,344
-26,486
| -30% | -$103K |
|
810
Greenlight Captial
GLRE
$563M
| $303K | 0.01% |
+35,173
| New | +$384K |
|
|
MODN
811
DELISTED
MODEL N, INC.
MODN
| $299K | 0.01% |
22,590
| – | – |
|
|
TTPH
812
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $299K | 0.01% |
13,233
+5,148
| +64% | +$201K |
|
813
Aon
AON
$77.3B
| $298K | 0.01% |
+2,050
| New | +$318K |
|
814
Agilysys
AGYS
$2.78B
| $297K | 0.01% |
20,698
-7,263
| -26% | -$114K |
|
815
Markel Group
MKL
$25B
| $292K | 0.01% |
281
-323
| -53% | -$353K |
|
|
CDTX
816
DELISTED
Cidara Therapeutics
CDTX
| $286K | 0.01% |
6,084
+145
| +2% | +$10.3K |
|
|
ISEE
817
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $285K | 0.01% |
237,547
-1,200
| -0.5% | -$2.33K |
|
|
CALA
818
DELISTED
Calithera Biosciences, Inc
CALA
| $283K | 0.01% |
3,523
-1,043
| -23% | -$103K |
|
819
Enpro
NPO
$7.05B
| $282K | 0.01% |
4,692
| – | – |
|
820
Marchex
MCHX
$79.7M
| $280K | ﹤0.01% |
105,757
-31,589
| -23% | -$89K |
|
|
INSY
821
DELISTED
Insys Therapeutics, Inc.
INSY
| $279K | ﹤0.01% |
+79,700
| New | +$554K |
|
822
Pultegroup
PHM
$24.5B
| $276K | ﹤0.01% |
10,620
| – | – |
|
|
NTGN
823
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
| $276K | ﹤0.01% |
+54,954
| New | +$385K |
|
824
Karyopharm Therapeutics
KPTI
$168M
| $275K | ﹤0.01% |
1,953
+6
| +0.3% | +$1.01K |
|
|
BMTC
825
DELISTED
Bryn Mawr Bank Corp
BMTC
| $275K | ﹤0.01% |
8,007
-700
| -8% | -$27.7K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2018 Portfolio in Review
As of Q4 2018, Jacobs Levy Equity Management held 1,139 positions worth $5.69B, down 19% from $7.05B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Jacobs Levy Equity Management's Q4 2018 filing shows 165 new, 376 increased, 380 reduced and 175 closed positions. Its largest new stake was Starbucks: 930,980 shares worth $60M. The largest sale was Dell, an estimated $45.2M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q4 2018 buy was Starbucks: 930,980 shares worth $60M.
- Jacobs Levy Equity Management added most to Celgene Corp in Q4 2018, an estimated $27.6M increase.
- Jacobs Levy Equity Management's biggest Q4 2018 reduction was Accenture, cutting an estimated $24M.
- Jacobs Levy Equity Management fully exited Dell in Q4 2018, selling an estimated $45.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 18% of its $5.69B portfolio in Q4 2018.
- Jacobs Levy Equity Management opened 165 new positions and closed 175 in Q4 2018.
- Jacobs Levy Equity Management's portfolio value fell 19% quarter-over-quarter to $5.69B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2018, filed 14 Feb 2019.